Cargando…

Target Motion Management in Breast Cancer Radiation Therapy

BACKGROUND: Over the last two decades, breast cancer remains the main cause of cancer deaths in women. To treat this type of cancer, radiation therapy (RT) has proved to be efficient. RT for breast cancer is, however, challenged by intrafractional motion caused by respiration. The problem is more se...

Descripción completa

Detalles Bibliográficos
Autores principales: Piruzan, Elham, Vosoughi, Naser, Mahdavi, Seied Rabi, Khalafi, Leila, Mahani, Hojjat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647788/
https://www.ncbi.nlm.nih.gov/pubmed/34626533
http://dx.doi.org/10.2478/raon-2021-0040
_version_ 1784610669340917760
author Piruzan, Elham
Vosoughi, Naser
Mahdavi, Seied Rabi
Khalafi, Leila
Mahani, Hojjat
author_facet Piruzan, Elham
Vosoughi, Naser
Mahdavi, Seied Rabi
Khalafi, Leila
Mahani, Hojjat
author_sort Piruzan, Elham
collection PubMed
description BACKGROUND: Over the last two decades, breast cancer remains the main cause of cancer deaths in women. To treat this type of cancer, radiation therapy (RT) has proved to be efficient. RT for breast cancer is, however, challenged by intrafractional motion caused by respiration. The problem is more severe for the left-sided breast cancer due to the proximity to the heart as an organ-at-risk. While particle therapy results in superior dose characteristics than conventional RT, due to the physics of particle interactions in the body, particle therapy is more sensitive to target motion. CONCLUSIONS: This review highlights current and emerging strategies for the management of intrafractional target motion in breast cancer treatment with an emphasis on particle therapy, as a modern RT technique. There are major challenges associated with transferring real-time motion monitoring technologies from photon to particles beams. Surface imaging would be the dominant imaging modality for real-time intrafractional motion monitoring for breast cancer. The magnetic resonance imaging (MRI) guidance and ultra high dose rate (FLASH)-RT seem to be state-of-the-art approaches to deal with 4D RT for breast cancer.
format Online
Article
Text
id pubmed-8647788
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-86477882021-12-20 Target Motion Management in Breast Cancer Radiation Therapy Piruzan, Elham Vosoughi, Naser Mahdavi, Seied Rabi Khalafi, Leila Mahani, Hojjat Radiol Oncol Review BACKGROUND: Over the last two decades, breast cancer remains the main cause of cancer deaths in women. To treat this type of cancer, radiation therapy (RT) has proved to be efficient. RT for breast cancer is, however, challenged by intrafractional motion caused by respiration. The problem is more severe for the left-sided breast cancer due to the proximity to the heart as an organ-at-risk. While particle therapy results in superior dose characteristics than conventional RT, due to the physics of particle interactions in the body, particle therapy is more sensitive to target motion. CONCLUSIONS: This review highlights current and emerging strategies for the management of intrafractional target motion in breast cancer treatment with an emphasis on particle therapy, as a modern RT technique. There are major challenges associated with transferring real-time motion monitoring technologies from photon to particles beams. Surface imaging would be the dominant imaging modality for real-time intrafractional motion monitoring for breast cancer. The magnetic resonance imaging (MRI) guidance and ultra high dose rate (FLASH)-RT seem to be state-of-the-art approaches to deal with 4D RT for breast cancer. Sciendo 2021-10-08 /pmc/articles/PMC8647788/ /pubmed/34626533 http://dx.doi.org/10.2478/raon-2021-0040 Text en © 2021 Elham Piruzan, Naser Vosoughi, Seied Rabi Mahdavi, Leila Khalafi, Hojjat Mahani, published by Sciendo https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Review
Piruzan, Elham
Vosoughi, Naser
Mahdavi, Seied Rabi
Khalafi, Leila
Mahani, Hojjat
Target Motion Management in Breast Cancer Radiation Therapy
title Target Motion Management in Breast Cancer Radiation Therapy
title_full Target Motion Management in Breast Cancer Radiation Therapy
title_fullStr Target Motion Management in Breast Cancer Radiation Therapy
title_full_unstemmed Target Motion Management in Breast Cancer Radiation Therapy
title_short Target Motion Management in Breast Cancer Radiation Therapy
title_sort target motion management in breast cancer radiation therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647788/
https://www.ncbi.nlm.nih.gov/pubmed/34626533
http://dx.doi.org/10.2478/raon-2021-0040
work_keys_str_mv AT piruzanelham targetmotionmanagementinbreastcancerradiationtherapy
AT vosoughinaser targetmotionmanagementinbreastcancerradiationtherapy
AT mahdaviseiedrabi targetmotionmanagementinbreastcancerradiationtherapy
AT khalafileila targetmotionmanagementinbreastcancerradiationtherapy
AT mahanihojjat targetmotionmanagementinbreastcancerradiationtherapy